🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Take a look 👐🏻

#AIOM24 inizia con importanti updates sulle possibilità di gravidanza dopo un tumore! 🔑 points: -> minore età alla diagnosi -> prima gravidanza in età più avanzata => dobbiamo aspettarci un aumento di questi casi! Luca Arecco, MD Università di Genova AIOM

È iniziato il congresso nazionale #AIOM24…foto immancabile con la delegazione AIOM Liguria che con orgoglio sosterrà la candidatura della Prof.ssa Lucia Del Mastro alle elezioni 2025 per la presidenza di AIOM !!! 🤩🔝💪🥰 Università di Genova Ospedale San Martino Genova OncoAlert Gil Morgan, MD

Super proud of our Università di Genova Ospedale San Martino Genova team rocking at AIOM #AIOM24 with 4 oral presentations discussing important data from #BRCABCYcollaboration to improve care of young #BRCA carriers with #BreastCancer Lucia Del Mastro Luca Arecco, MD Eva Blondeaux Maria Grazia Razeti OncoAlert

So proud to present the results of our analysis from #BRCABCYcollaboration on the safety of #ART in young #BRCA carriers after BC at the AIOM National Congress 2024. A crucial step toewards a safer future for our patients. #BreastCancer #BRCA #AIOM24

Final tweet from #AIOM24 to congratulate Dr. Eva Blondeaux from Università di Genova Ospedale San Martino Genova for winning the most important recognition in 🇮🇹 for a young oncologist, the #MarcoVenturini award lecture for our JAMA paper on safety of pregnancy in #BRCA carriers 👏 OncoAlert

Ad #AIOM24 ho presentato i dati sul nostro studio di validazione del Predict tool in early BC pts! 🔎 🔼 PREDICT sottostima l'OS a 5 e 10aa ⏫ La performance è più bassa in alcuni sottogruppi (es. HER2+ e BMI>25) 👌 Predict rimane un ottimo strumento Università di Genova AIOM

As physicians we should offer best care to our patients, including those strategies to return to a normal life after treatments. In 📬 JCO Oncology Practice we underline the importance of #fertility preservation in #young patients 📌 ascopubs.org/doi/pdf/10.120… Matteo Lambertini, MD PhD OncoAlert #bcsm

Clear and intuitive flowchart for choosing the best adjuvant endocrine therapy in pts with HR+/HER2- breast cancer. 2 more points: 📌 Consider also the recently FDA/EMA approved #ribociclib 📌 Consider enrollment in clinical trials for #extended adj ET OncoAlert #bcsm

So much looking forward to this presentation by Icro Meattini in general session 2 at SABCS #SABCS24 in one week from now!!! OncoAlert ESMO - Eur. Oncology Rebecca Dent Kevin Punie Belinda Kiely #ESMOpreceptorship #BreastCancer #bcsm

Let’s start with Matteo Lambertini, MD PhD at #SABCS24 Educational Session 1 about young #BreastCancer women💪🏼OncoAlert

Thank you very much for selecting our work for the press program of such an important event as SABCS…hope these data will help to improve the care of young #BRCA carriers with #BreastCancer OncoAlert Università di Genova Ospedale San Martino Genova #bcsm AACR VIRGINIA KAKLAMANI #SABCS24

Updated results from #OlympiA trial presented by judy garber in GS1 at #SABCS24 Maintained benefit of adjuvant Olaparib in pts harboring BRCA PV at high risk of recurrence: + 4.4% OS + 7.8% DDFS + 9.4% iDFS ⬇️ 2nd primary cancers in Olaparib arm Breast International Group OncoAlert

Such a pleasure to host this incredible group of colleagues from Turkey 🇹🇷 at Università di Genova Ospedale San Martino Genova…looking forward to future collaborations 💪 thanks a lot for coming! OncoAlert Deniz Can Guven Marco Tagliamento Lucia Del Mastro

Proud to present the first results of our meta-analysis trying to address the association between alcohol consumption on both breast cancer #incidence and #prognosis. A big thanks to all the authors and to Evandro de Azambuja, MD, PhD for leading these projects! OncoAlert ESMO - Eur. Oncology #bcsm

No comments needed 🤩🥳😍 congrats super Sara Tolaney from Dana-Farber and all involved in the #DB09 trial !!!! #ASCO25 OncoAlert ASCO Dana-Farber’s Breast Oncology Center

In the era of immunotherapy and targeted agents, oncofertility and reproductive counselling after cancer are becoming increasingly complex. In our latest review in Human Reproduction ESHRE we address major evidence in this field. Thank you Matteo Lambertini, MD PhD and all coauthors! OncoAlert

23ª Conferenza Nazionale AIOM: oncologi, associazioni pazienti e metodologi INSIEME per linee guida condivise e centrate sul paziente. Orgogliosi del contributo dell’oncologia genovese Università di Genova Ospedale San Martino Genova: linee guida carcinoma della prostata e preservazione della fertilità

Torno da #AIOMGiovani con nuove idee, tanta energia e orgogliosamente convinto di sostenere Lucia Del Mastro alla Presidenza AIOM con l’obiettivo di far crescere fattivamente e #INSIEME un’AIOM fondata su innovazione, network, inclusività, mentorship ed eccellenza! 💪🌱

Forza Lucia Del Mastro…tutti #INSIEME…per AIOM !!!! OncoAlert Università di Genova Luca Arecco, MD Francesca Poggio Marco Tagliamento Davide Soldato Carlo Genova Maria Grazia Razeti ChiaraMolinelli Andrea Boutros